Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 1,820 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Brow Ptosis, Lid Ptosis
Interventions: Dysport; Drug
Lead sponsor: Kenneth Beer; Individual
Eligibility: 25 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: West Palm Beach, Florida

Conditions: Renal Disease, Renal Insufficiency
Interventions: Iohexol; Drug
Lead sponsor: University of Washington; Other
Eligibility: 2 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Neuroendocrine Neoplasms
Interventions: BI 764532, Carboplatin, Etoposide, Cisplatin; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Miami, Florida • Atlanta, Georgia • Chicago, Illinois + 2 more

Conditions: Chronic Stroke, Healthy Aging
Interventions: Cognitive-motor exergaming, Conventional balance Training, Dance Therapy for Stroke, Dance Therapy for Older adults, Home education for Older adults; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 90 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: No drug will be used; Other
Lead sponsor: MedImmune LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 12
States / cities: Denver, Colorado • Normal, Illinois • Baltimore, Maryland + 9 more

Conditions: Vaccine Refusal, Covid19
Interventions: COVID-19 Individual Awareness and Education., COVID-19 Community Outreach & Health Promotion., COVID-19 Individual Health Education & Linkages to Medical and Supportive Services., Pop-up community vaccination sites; Behavioral · Biological
Lead sponsor: Britt Skaathun; Other
Eligibility: 16 Years to 99 Years
Enrollment: 1,051 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 6
States / cities: Chula Vista, California • San Diego, California • San Ysidro, California

Conditions: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Interventions: BI 1839100, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 18
States / cities: Birmingham, Alabama • Lakewood, Colorado • Kissimmee, Florida + 14 more

Conditions: Crohn's Disease
Interventions: Brazikumab IV Infusion, Brazikumab SC Injection, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 52
States / cities: Phoenix, Arizona • Lone Tree, Colorado • Clearwater, Florida + 25 more

Conditions: Infant, Newborn
Interventions: DVD/Video; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Calorie Consumption
Interventions: Black-Food, White-Food, Black-Non Food, White-Non Food, Food-Many Likes, Non Food-Many Likes, Food-Few Likes, Non Food-Few; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 13 Years to 17 Years
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: COMT Gene Polymorphism
Interventions: delta 9 tetrahydrocannabinol; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Smoking Cessation
Interventions: NRT, Web Guide, Tweet2Quit; Drug · Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 21 Years to 59 Years
Enrollment: 980 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Irvine, California • Stanford, California

Conditions: Depression in Adolescence, Suicidal Ideation, Social Media Addiction, Mental Health Issue
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 13 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Breast Carcinoma
Interventions: Educational Intervention, Usual Care, Media Intervention, Medical Chart Review, Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Carcinoma
Interventions: Electronic Health Record Review, Interview, Media Intervention, Survey Administration, Training and Education; Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 40 Years to 74 Years · Female only
Enrollment: 1,141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Alzheimer Disease
Interventions: RB-ADSC; Biological
Lead sponsor: Regeneration Biomedical, Inc.; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Diabetes
Interventions: BE-EHR module; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 75 Years and older
Enrollment: 7,630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Otitis Media With Effusion, Food Hypersensitivity
Interventions: Food Allergy Testing, Adenoidectomy, BMT; Other · Procedure
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: Up to 4 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Substance Use
Interventions: REAL media curriculum; Behavioral
Lead sponsor: Real Prevention, LLC; Industry
Eligibility: 13 Years and older
Enrollment: 642 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Epilepsy, Epilepsy Intractable, Seizures, Seizure Disorder, Ketogenic Dieting, Ketosis
Interventions: Betaquik; Dietary Supplement
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Mental and Behavioral Disorders, Mental Resilience, Emotional Awareness, Emotional Development
Interventions: ThinkHumanTV; Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Diabetic Nephropathy
Interventions: VPI-2690B low dose, VPI-2690B medium dose, Placebo to match VPI-2690B, VPI-2690B high dose; Drug
Lead sponsor: Vascular Pharmaceuticals, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 32
States / cities: Birmingham, Alabama • Little Rock, Arkansas • La Mesa, California + 29 more

Conditions: Acute Pancreatitis, Systemic Inflammatory Response Syndrome
Interventions: CM-4620 Injectable Emulsion or CM-4620-IE, Placebo; Drug · Other
Lead sponsor: CalciMedica, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 27
States / cities: Long Beach, California • Los Angeles, California • Orange, California + 21 more

Conditions: Hypertension
Interventions: Booster/ low resource, Medium/Level 1 resource intensity, High/Level 2 resource intensity; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 385 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Brow Lifting With Dysport

Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Alternative Therapies for Improving Motor Impairment, Fall-risk and Overall Physical Function

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Newborn Health Information Study

Effects of Racial Congruence, "Likes", and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3

Pharmacogenetics of Cannabinoid Response

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)

Social Media Concerns Related to Emotional Experiences in Naturalistic Settings (SCREENS)

Development of a Patient Decision Aid for Women Considering Breast Reconstruction

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

A Randomized Trial of a BE-EHR Module to Guide the Care of Older Adults With Diabetes

Food Allergy - Tubes - Adenoids (FATA) Trial

Interactive Technology for Media Literacy Drug Prevention in Community Groups

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

Media and Mental Health

Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients

A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS

Titrated Disease Management for Patients With Hypertension